ABBV | AbbVie Earnings Transcripts - StockLight

Jul 27, 2023 · AbbVie; Earnings Transcripts AbbVie Earnings Transcripts NYSE:ABBV (302.3B) Date Transcript Closing Price October 30th, 2024 Q3 2024 Earnings Call Transcript: $201.50 …

CouponFollow Extension

$201.50
OFF

ABBV | AbbVie Earnings Transcripts - StockLight

1 week from now

Jul 27, 2023 · AbbVie; Earnings Transcripts AbbVie Earnings Transcripts NYSE:ABBV (302.3B) Date Transcript Closing Price October 30th, 2024 Q3 2024 Earnings Call Transcript: $201.50 …

stocklight.com

10%
OFF

AbbVie (NYSE:ABBV) Stock Price News - Stocklight.com

1 week from now

ABBV. UNATTRACTIVE : AbbVie exhibits an implied growth ratio which exceeds the industry average for drug manufacturers - general stocks listed on the NYSE. ABBV calculation: 10% - …

stocklight.com

$2.31
OFF

AbbVie Inc. (NYSE:ABBV) Q1 2024 Earnings Call Transcript

1 week from now

Apr 30, 2024 · AbbVie Inc. (NYSE:ABBV) Q1 2024 Earnings Call Transcript April 26, 2024 AbbVie Inc. beats earnings expectations. Reported EPS is $2.31, expectations were $2.26. AbbVie …

yahoo.com

92%
OFF

AbbVie (ABBV) Q4 2021 Earnings Call Transcript - The Motley Fool

1 week from now

Feb 3, 2022 · ABBV earnings call for the period ending December 31, 2021. ... AbbVie (ABBV-1.92%) Q4 2021 Earnings Call Feb 02, 2022, ... More ABBV analysis. All earnings call …

fool.com

$3.11
OFF

AbbVie (ABBV) Q2 2021 Earnings Call Transcript - The Motley Fool

1 week from now

Jul 31, 2021 · AbbVie delivered another excellent quarter with adjusted earnings per share of $3.11, exceeding the midpoint of our guidance by $0.04. Total adjusted net revenues of nearly …

fool.com

$136.30
OFF

William Blair Issues Positive Outlook For AbbVie Earnings

1 week from now

3 days ago · AbbVie has a 12 month low of $136.30 and a 12 month high of $207.32. The firm has a market cap of $301.23 billion, a price-to-earnings ratio of 59.19, a P/E/G ratio of 2.08 …

marketbeat.com

FAQs about ABBV | AbbVie Earnings Transcripts - StockLight Coupon?

When will AbbVie Inc (ABV) stock report earnings?

AbbVie Inc. Common Stock is expected* to report earnings on 07/25/2024 before market open. The report will be for the fiscal Quarter ending Jun 2024. According to Zacks Investment Research, based on 6 analysts' forecasts, the consensus EPS forecast for the quarter is $2.57. The reported EPS for the same quarter last year was $2.91. ...

Is AbbVie Inc (abbv) a good stock to buy?

AbbVie Inc.'s (NYSE:ABBV) stock was strong despite it releasing a soft earnings report last week. We think that investors might be looking at some positive factors beyond the earnings numbers. See our latest analysis for AbbVie ...

How much money does AbbVie make a year?

AbbVie (NYSE:ABBV) has a recorded annual revenue of $54.32 billion. How much profit does AbbVie generate each year? AbbVie (NYSE:ABBV) has a recorded net income of $4.86 billion. ABBV has generated $2.88 earnings per share over the last four quarters. ...

Is AbbVie's statutory earnings less than its free cashflow?

Over the twelve months to September 2024, AbbVie recorded an accrual ratio of -0.16. Therefore, its statutory earnings were very significantly less than its free cashflow. Indeed, in the last twelve months it reported free cash flow of US$16b, well over the US$5.08b it reported in profit. ...

Can I listen to the AbbVie fourth quarter 2023 earnings conference call?

Operator: Good morning, and thank you for standing by. Welcome to the AbbVie Fourth Quarter 2023 Earnings Conference Call. All participants will be able to listen-only until the question-and-answer portion of this call. [Operator Instructions] Today's call is also being recorded. If you have any objection, you may disconnect at this time. ...

How did AbbVie perform compared to consensus earnings estimates?

The company provided EPS guidance of 2.940-2.980 for the period, compared to the consensus earnings per share estimate of 2.950. The company issued revenue guidance of $14.8 billion-$14.8 billion, compared to the consensus revenue estimate of $14.6 billion. Did AbbVie beat their earnings estimates last quarter? ...